Meetings of the Minds2000

2000 GRC ON MEDICAL CHEMISTRY

  • DAY: to be released
  • Place:COLBY-SAWYER COLLEGE, NEW LONDON, NH, U.S.A
  • Calpain inhibitors for cataracts and retinal degeneration
  • Chair: Graham Johnson BMS
    Vice-Chair: Kelvin Cooper Pfize
    r Chair: Kelvin Cooper Pfizer
    Discussion Leader: Michael Rafferty, Parke-Davis, Warner-Lambert, Jun Inoue (Senju Pharmaceuticals)

Fourth Australia / Japan joint symposium on Drug Design and Development

  • DAY: to be released
  • Place:Melbourne, Australia
  • Structure-activity relationship study and anti-cataract activity of N-sulfonyl-dipeptide aldehyde as a potent calpain inhibitor
  • Jun Inoue, Masayuki Nakamura, Yoshiyuki Tamada, TYoshikuni Nakamura,Osamu Sakai, and Mitsuyoshi Azuma

The Association for Research in Vision and Ophthalmology (ARVO)

  • DAY: to be released
  • Place:Florida, U.S.A.

● Tittle List
<< Poster >>
 ・CALPAIN     M. Azuma
  UV-B Oxidation Enhances Calpain-Induced Light Scattering in Young Rat Lenses.
 ・CALPAIN     C. Fukiage
  Tissue Specific Calpains from Rat Retina.
 ・CALPAIN     T. Nakajima
  Involvement of Calpain Isoforms in Ischemia-Reperfusion Injury in Rat Retina.      

3rd International Symposium on Ocular Pharmacology and Pharmaceutics(ISOPP)

  • DAY: to be released
  • Place:Lisbon, PORTUGAL

● NTERNATIONAL ADVISORY BOARD
<Scientific Advisory Board in Japan>
N. Araie (University of Tokyo) , Y. Honda (Kyoto University), K. kitazawa (Gifu University), S. Kinoshita (Kyoto Prefectural University of Medicine), K. Tsubota (Tokyo Dental College), S. Kashii (Kyoto University), T. Hiramitsu (Hamamatsu University School of Medicine), H. Nishigori (Teikyo University), A. Okumura (Senju Pharmaceutical Ltd.,)

● Tittle List
<< Sponsored Product Session >>
 ・BROMFENAC     M. Isaka
  A new cyclooxygenase inhibitor as analgestic and anti-inflammatory agent
 ・GATIFLOXACIN    A. Okumura
  New 8-methoxy quinolone, gatifloxacin
 ・RISARESTAT(CT-112)    T. Kikuya
  Topical aldose reductase inhibitor, risarestat(CT-112), for diabetic keratopathy

<< Oral presentation or Poster >>
 ・TA-2711    H. Tokushige
  Effect of Ecabet Sodium on Secretion of Mucin-like Glycoproteins in Ocular Surface
 ・DIFLUPREDNATE    M. Yamaguchi
  Studies on Intraocular Penetration of Steroid Ophthalmic Emulsion
 ・BROMFENAC    M. Isaka
  Bromfenac Safety to Liver : A Case for Ophthalmic Administration
 ・TIMOLOL-LA    M. Higashiyama
  Ocular Bioavailability Improved by Computer Simulation
 ・SJA-6017    Y. Sakamoto
  Protection by a Calpain Inhibitor of Neuronal Cells from Ischemic Injury in Retina
 ・ROCK INHIBITOR    M. Waki
  Rho-kinase Inhibitor, Y-27632, as a Possible Anti-glaucomatous Drug
 ・Rt 88    C. Fukiage
  Tissue Specific Caplains in the Eye

new | 2015 | 2014 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999